Category Archives: Regulatory Relief

The FDA and Regulation – Neurosurgery Partners with FDA for Patient Safety, Innovation and Regulatory Reform

Clemens M. Schirmer, MD, PhD, FAANS, FAHA (left) Vice-Chair, AANS/CNS Communications and Public Relations Committee Geisinger Wilkes Barre, PA Catherine Jeakle Hill (right) Senior Manager for Regulatory Affairs, Washington Office American Association of Neurological Surgeons (AANS) Congress of Neurological Surgeons … Continue reading

Posted in Access to Care, Drugs and Devices, Guest Post, Health, Medical Innovation, Patient Safety, Regulatory Relief | Tagged , , , , , , , , , , |

MIPS, Cost Measures and Innovation from a Neurosurgical Perspective

Clemens M. Schirmer, MD, PhD, FAANS, FACS, FAHA Vice-Chair, AANS/CNS Communications and Public Relations Committee Geisinger Wilkes Barre, PA The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is a law that reformed the Medicare payment system by repealing … Continue reading

Posted in Guest Post, MACRA, Regulatory Relief | Tagged , , , , , , , , , , , , , , , |

Unnecessary Regulatory Burden: Appropriate Use Criteria for Advanced Diagnostic Imaging

Ann R. Stroink, MD, CPE, FAANS Chair, AANS/CNS Washington Committee System Medical Director, Neurosciences Quality and Educational Program Development Senior Neurosurgeon CINHS Central Illinois Neuro Health Science Bloomington, IL   Ordering X-rays or other diagnostic imaging used to be purposeful and easy. Physicians, … Continue reading

Posted in Access to Care, Congress, Guest Post, Health, Healthcare Costs, MACRA, Medicare, Regulatory Relief | Tagged , , , , , , , , , , , , , , , , , , , |